Vor BioPharma

VOR

21.80011.51% ( +2.250 )

已收盘: 7月30日 16:00:00 (美东)

VOR

21.80011.51% ( +2.250 )

已收盘: 7月30日 16:00:00 (美东)

主要股东最新
股东
TCG Crossover Management, LLC	10.47%	567.31 万	--	+567.31 万	2026/03/31
RA Capital Management, L.P.	8.31%	450.19 万	1.67%	-90.31 万	2026/07/16
Forbion Capital Partners B.V.	7.60%	411.74 万	1.74%	+50.00 万	2026/03/31
VR Management, LLC	5.61%	304.17 万	0.59%	+109.80 万	2026/03/31
Frazier Life Sciences Management, LP	4.69%	254.39 万	1.88%	+0	2026/03/31
Qiming Weichuang Venture Capital Management (Shanghai) Company Limited	3.69%	199.99 万	1.47%	+0	2026/03/31
Caligan Partners, LP	3.55%	192.51 万	1.16%	+100.00 万	2026/03/31
Great Point Partners, LLC	3.23%	175.00 万	0.31%	+37.99 万	2026/03/31
Paradigm Biocapital Advisors LP	3.23%	175.00 万	1.29%	+0	2026/03/31
FMR LLC	2.84%	153.97 万	3.68%	-98.65 万	2026/03/31
Vanguard Capital Management, LLC	2.65%	143.33 万	--	+143.33 万	2026/03/31
Reid Hoffman	2.15%	116.69 万	0.86%	+0	2025/10/21
Marshall Wace LLP	2.13%	115.33 万	--	+115.33 万	2026/03/31
State Street Global Advisors, Inc.	2.06%	111.85 万	1.83%	+102.74 万	2026/03/31
Nextbio Capital Management LP	1.85%	100.00 万	0.74%	+0	2026/03/31
BlackRock, Inc.	1.47%	79.48 万	0.26%	+32.91 万	2026/03/31
Logos Global Management, L.P.	1.38%	75.00 万	1.13%	+65.00 万	2026/03/31
Rosalind Advisors, Inc.	1.29%	70.00 万	--	+70.00 万	2026/03/31
Nan Fung Trinity (HK) Limited	1.19%	64.66 万	--	+64.66 万	2026/06/30
Boothbay Fund Management, LLC	1.03%	55.57 万	--	+55.57 万	2026/03/31

全部股东